Can-Fite BioPharma Ltd. Quarterly Assets in USD from Q4 2018 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Can-Fite BioPharma Ltd. quarterly Assets history and growth rate from Q4 2018 to Q4 2023.
Can-Fite BioPharma Ltd. Assets for the quarter ending December 31, 2023 was $9.99M, a 7.61% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$9.99M	+$706K	+7.61%	Dec 31, 2023	20-F	2024-03-28
Q2 2023	$11M	-$3.71M	-25.2%	Jun 30, 2023	6-K	2023-08-31
Q4 2022	$9.28M	-$11M	-54.2%	Dec 31, 2022	20-F	2024-03-28
Q2 2022	$14.7M	+$5.07M	+52.3%	Jun 30, 2022	6-K	2022-08-25
Q4 2021	$20.3M	+$10.7M	+113%	Dec 31, 2021	20-F	2023-03-30
Q2 2021	$9.68M	-$3.12M	-24.4%	Jun 30, 2021	6-K	2021-08-26
Q4 2020	$9.52M	+$1.35M	+16.5%	Dec 31, 2020	20-F	2022-03-24
Q2 2020	$12.8M	-$867K	-6.34%	Jun 30, 2020	6-K	2020-08-27
Q4 2019	$8.17M	+$222K	+2.79%	Dec 31, 2019	20-F	2021-03-25
Q4 2018	$7.95M	+$338K	+4.44%	Dec 31, 2018	6-K	2020-06-01

* An asterisk sign (*) next to the value indicates that the value is likely invalid.